Back
iShares Core US REIT ETF Vs. Rigel Pharmaceuticals, Inc. Industry Stock Comparison
Buy
65
USRT
iShares Core US REIT ETF
Last Price:
$56.96
Seasonality Move:
1.9%
Buy
72
RIGL
Rigel Pharmaceuticals, Inc.
Last Price:
$42.37
Seasonality Move:
-1.35%
Buy
65
iShares Core US REIT ETF (USRT)
is a Buy
Is iShares Core US REIT ETF a Buy, Sell or Hold?
-
The current iShares Core US REIT ETF [USRT] share price is $57.07. The Score for USRT is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
-
USRT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
72
Rigel Pharmaceuticals, Inc. (RIGL)
is a Buy
Is Rigel Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Rigel Pharmaceuticals, Inc. [RIGL] share price is $41.94. The Score for RIGL is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
-
RIGL is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
USRT Stock Price Chart
What is iShares Core US REIT ETF's stock price today?
-
The iShares Core US REIT ETF share price today is $57.07Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and USRT is experiencing slight buying pressure.
RIGL Stock Price Chart
What is Rigel Pharmaceuticals, Inc.'s stock price today?
-
The Rigel Pharmaceuticals, Inc. share price today is $41.94Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RIGL is experiencing slight selling pressure.
USRT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.55 | Buy |
| Relative Strength Index (14 RSI): | 42.44 | Sell |
| Chaikin Money Flow: | 79687 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (57.26 - 58.36) | Sell |
| Bollinger Bands (100): | (56.91 - 58.71) | Sell |
RIGL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.35 | Buy |
| Relative Strength Index (14 RSI): | 49.24 | Sell |
| Chaikin Money Flow: | -59488 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (41.15 - 48.01) | Sell |
| Bollinger Bands (100): | (28.46 - 42.96) | Buy |
USRT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 57.36 | Sell |
| 20-day SMA: | 57.81 | Sell |
| 50-day SMA: | 58.01 | Sell |
| 200-day SMA: | 57.2 | Sell |
| 8-day EMA: | 12.68 | Buy |
| 20-day EMA: | 5.44 | Buy |
| 50-day EMA: | 2.24 | Buy |
| 200-day EMA: | 0.57 | Buy |
RIGL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 42.03 | Sell |
| 20-day SMA: | 45.2 | Sell |
| 50-day SMA: | 37.61 | Buy |
| 200-day SMA: | 27.44 | Buy |
| 8-day EMA: | 9.32 | Buy |
| 20-day EMA: | 3.99 | Buy |
| 50-day EMA: | 1.64 | Buy |
| 200-day EMA: | 0.42 | Buy |
iShares Core US REIT ETF Earnings Growth & USRT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Rigel Pharmaceuticals, Inc. Earnings Growth & RIGL Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.35 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.13 per share, and a decrease next year of $2.31 per share.
iShares Core US REIT ETF Technical Analysis
| Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Rigel Pharmaceuticals, Inc. Technical Analysis
| Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||